삼성서울병원

Ko En

Park, Keun Chil M.D

TITLE
Treament Schedule 07 月
날짜 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
오전
오후
Treament Schedule 08 月
날짜 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
오전
오후

Medical School

Specialty Training

Fellowship   
Residency   
Internship   

Other Education

Specialty Interests

Participation in Academic Societies
and Research

Thesis

  • J THORAC ONCOL 2019 10.1016/j.jtho.2019.10.010 In Reply: DDR Pathway Alteration, Tumor Mutation Burden and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole-Exome and Targeted-Gene Sequencing Park1, S; Lee, SH; Park, K
    View PubMed
  • LANCET ONCOL 2019 10.1016/S1470-2045(19)30634-5 Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial Nakagawa1, K; Garon, EB; Seto, T; Nishio, M; Aix, SP; Paz-Ares, L; Chiu, CH; Park, K; Novello, S; Nadal, E; Imamura, F; Yoh, K; Shih, JY; Au, KH; Moro-Sibilot, D; Enatsu, S; Zimmermann, A; Frimodt-Moller, B; Visseren-Grul, C; Reck, M
    View PubMed
  • INT J CANCER 2019 10.1002/ijc.32235 Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease Shin1, SH; Park, HY; Im, Y; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, HY; Lee, SH
    View PubMed
  • EUR J CANCER 2019 10.1016/j.ejca.2019.08.001 Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing Kim1, HS; Cha, H; Kim, JH; Park, WY; Choi, YL; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2019 10.3904/kjim.2017.234 Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck Kim1, MJ; Kim, SM; Jung, HA; Hong, JY; Chang, WJ; Choi, MK; Kim, HS; Sun, JM; Park, K; Ahn, MJ
    View PubMed